Enanta Pharma (ENTA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov18

Enanta Pharma released FY2025 Annual Earnings on November 17 After-Market (EST), actual revenue USD 65.32 M (forecast USD 66.15 M), actual EPS USD -3.838 (forecast USD -3.7725)

00:00

Enanta Pharma released FY2025 Q4 earnings on November 17 After-Market (EST), actual revenue USD 15.13 M (forecast USD 15.97 M), actual EPS USD -0.8746 (forecast USD -1.014)

00:00

Nov10

Enanta Pharma to release FY2025 Q4 earnings on November 17 After-Market EST, forecast revenue USD 15.97 M, EPS USD -1.014

00:05

Oct20

Enanta to Present New Data on RSV Drug Candidates at IDWeek

11:01

Oct7

Enanta Pharmaceuticals Reports Positive Clinical Trial Results for RSV Research Drugs

11:00

Oct2

Enanta Pharmaceuticals Completes $74.75 Million Increased Offering of Common Stock